Evaluation of pharmacy-based HIV testing in a high-risk New York city community

Silvia Amesty, Natalie D. Crawford, Vijay Nandi, Rafael Perez-Figueroa, Alexis Rivera, Madeline Sutton, Paul J. Weidle, Leigh Willis, Dawn K. Smith, Carolyn Hernandez, Katherine Harripersaud, Crystal Fuller Lewis

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


Blacks/Hispanics face limited access to HIV testing. We examined in-pharmacy HIV testing among customers in pharmacies participating in a nonprescription syringe program in New York City. Participants were recruited in two pharmacies to complete a survey and receive an optional HIV test. Bivariate and multivariable analyses were performed to examine associations of demographics and risk behaviors with receiving in-pharmacy HIV testing. Most participants were male (55%), black (80%), had used hard drugs (88%), and 39.5% received in-pharmacy HIV testing. Being female (AOR=2.24; 95%CI 1.24-4.05), having multiple sex partners (AOR=1.20; 95% CI 1.06-1.35), having an HIV test more than 12 months ago (AOS=4.06; CI 1.85-8.91), injecting drugs in last 3 months (AOR=2.73; 95% CI 1.31-5.69) and having continuous care (AOR=0.32; 95% CI 0.17-0.58) were associated with receiving in-pharmacy HIV test. These data provide evidence of in-pharmacy HIV testing reaching persons at risk of HIV. HIV testing in pharmacies may complement existing strategies.

Original languageEnglish
Pages (from-to)437-444
Number of pages8
JournalAIDS Patient Care and STDs
Issue number8
StatePublished - Aug 1 2015

Bibliographical note

Publisher Copyright:
© Mary Ann Liebert, Inc. 2015.

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'Evaluation of pharmacy-based HIV testing in a high-risk New York city community'. Together they form a unique fingerprint.

Cite this